Gene expression is certainly relative to adult articular chondrocytes (AC)1 in the absence of IL-1 for each respective gene; *p <0. 01 Juvenile (n=2 donors) and adult chondrocytes (n=2 donors) were further utilized for the single cell flow cytometry analyses. of CD24 in chondrocytes subsequently increased inflammatory and catabolic gene expression both in the absence and presence of IL-1. == Conclusions == We have identified CD24 as a novel regulator of MK-2206 2HCl inflammatory response in cartilage that is modified during development and aging and could potentially be therapeutic in RA and OA. == Electronic supplementary material == The online version of this article (doi: 10. 1186/s13075-016-1183-y) contains supplementary material, which is accessible to authorized users. Keywords: Cartilage, CD24, inflammation, OA == Background == Cartilage degenerative diseases like rheumatoid arthritis (RA) and osteoarthritis (OA) possess inflammation, age group and obesity as causal risk factors; however , the precise molecular mechanisms underlying these risk factors are ill-understood. No disease-modifying drug is available for OA, while the drugs available for RA are not equally effective in all patients. Increased molecular understanding of the causal factors will therefore be beneficial in both diseases. Very few studies have systematically evaluated the age-dependent changes in human tissue including cartilage due to limited availability of human being cartilage tissue. These studies are particularly pertinent to cartilage because cartilage regeneration is inefficient even in healthy young adults, often leading to OA, even though pediatric patients demonstrate superior cartilage repair. Recently, allogeneic juvenile cartilage (from donors below 13 years of age) Rabbit polyclonal to ITLN2 offers even been successfully utilized for repair of focal cartilage defects. Upon phenotypic and functional characterization of juvenile and adult chondrocytes, it was found that juvenile chondrocytes demonstrate increased cell proliferation and extracellular matrix (ECM) generation as compared to the adult chondrocytes [1]. The molecular factors responsible for these functional differences that define the regenerative capacity of juvenile and adult chondrocytes possess, however , not been characterized. Another important question that remains unanswered is how age-related changes modulate the cell and tissue-specific response to inflammation. Inflammaging, i. e. systemic upregulation of inflammatory cues with aging is a well-documented phenomenon. For example , plasma levels of the pro-inflammatory cytokine, interleukin-6 (IL-6) are low in young adults and begin to increase in healthy people at about 5060 years of age [2]. Inflammaging is associated with many forms of MK-2206 2HCl age-related pathological conditions, such as neurodegeneration, atherosclerosis, metabolic syndrome, diabetes mellitus and conditions influencing the musculoskeletal system (i. e. osteoporosis, OA and RA) [3, 4]. However , it remains unclear whether the age-related changes in tissues render them increasingly susceptible to the inflammaging cues, thereby leading to increased inflammation-mediated damage in aging tissues. To address the effects of age-related MK-2206 2HCl changes in cartilage regeneration and degeneration, we have recently performed genome-wide gene expression profiling of juvenile and adult chondrocytes [5]. Impressive phenotypic and functional differences have been reported between juvenile and adult human chondrocytes, demonstrating the characteristic functional differences such as increased ECM production by the juvenile chondrocytes compared to adult chondrocytes [6, 7]. In order to dissect the underlying biological differences that lead to the observed increased regenerative capability of juvenile chondrocytes [5, 7], we have compared the molecular differences between the juvenile and adult articular chondrocytes by utilizing exon microarrays to determine their global gene expression profiles [5]. Multiple previous studies have recognized cell-surface cluster of differentiation (CD) molecules including CD44 (the hyaluron receptor), CD90 (Thy 1) and CD49 (alpha integrins) to play critical roles in and be markers of the chondrogenic capacity of chondrocytes [811]. Among approximately 600 factors that were differentially upregulated in juvenile chondrocytes, our studies recognized CD24 to be highly enriched in juvenile chondrocytes with expression being lost with age such that the adult chondrocytes only demonstrate a modest expression. CD24 is a small , heavily glycosylated and glycosyl-phosphatidylinositol (GPI)-anchored cell-surface protein that is a co-stimulator for antigen-specific T cell responses and a differentiation marker intended for B cells [12, 13]. Importantly, polymorphisms of human CD24 are associated with risk and progression of several autoimmune diseases, multiple sclerosis and RA [1417]. In this study, we provide MK-2206 2HCl evidence for a novel role for CD24 in cartilage function whereby it can negatively modulate NFB activity and hence the response to inflammatory cues. == Methods == == Chondrocyte isolation and culture == Four individual juvenile and four individual adult samples were analyzed in the study. The juvenile articular chondrocytes (from a 24-week aged fetus (designated as J1), a 6-year-old child (J2), and a 6-month-old (J3) and an 18-month (J4) infant) were purchased from Lonza (Clonetics, Lonza.